A case of successful conversion from everolimus to surgical resection of a giant pancreatic neuroendocrine tumor

A case of successful conversion from everolimus to surgical resection of a giant pancreatic neuroendocrine tumor

Abstract Background Although pancreatic neuroendocrine tumors generally have a far better prognosis relative to pancreatic cancer, the varied manifestations lead to treatment-related challenges. Everolimus therapy is generally recommended for patients with advanced pancreatic neuroendocrine tumors;...

Full description

Bibliographic Details
Main Authors: Asahi Sato, Toshihiko Masui, Nao Sankoda, Kenzo Nakano, Yuichiro Uchida, Takayuki Anazawa, Kyoichi Takaori, Yoshiya Kawaguchi, Shinji Uemoto
Format: Article
Language:English
Published: SpringerOpen 2017-07-01
Series:Surgical Case Reports
Subjects:
Neuroendocrine tumor
Everolimus
Sunitinib malate
68Ga-DOTATOC-PET/CT
Online Access:http://link.springer.com/article/10.1186/s40792-017-0361-8

Internet

http://link.springer.com/article/10.1186/s40792-017-0361-8

Similar Items